微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -3.61% | -140.67% | -222.32% | 122/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -1.12% | -115.38% | -1033.33% | 113/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.12% | -67.57% | 103.99% | 108/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -3.01% | -234.98% | -100.67% | 109/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -1.5% | -161.98% | -188.46% | 120/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -0.52% | -137.68% | -240.54% | 118/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.37% | -13.95% | -83.41% | 106/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 2.23% | -50.33% | -7.85% | 86/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 2.42% | -49.16% | 75.36% | 99/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.38% | -54.75% | 220.93% | 95/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.43% | -73.13% | -90.42% | 110/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 4.49% | -39.89% | -5.67% | 76/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 4.76% | -50.57% | 56.07% | 67/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 3.05% | -51.59% | 90.63% | 66/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.6% | -43.26% | -78.58% | 71/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 7.47% | -17.73% | -22.43% | 61/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 9.63% | 2% | 52.86% | 34/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 6.3% | 94.44% | 123.4% | 37/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.82% | 2% | -68.94% | 46/158 | 2.47% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 9.08% | -30.58% | 180.25% | 60/158 | 3.66% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 3.24% | 2% | -75.23% | 72/158 | 4.23% | 汇宇制药 | 55.94% | 行业排名> |
| 2019-12-31 | 13.08% | -30.13% | -30.13% | 36/158 | 2.57% | 河化股份 | 45.32% | 行业排名> |
| 2018-12-31 | 18.72% | -30.31% | -30.31% | 17/158 | 7.17% | 汇宇制药 | 31.9% | 行业排名> |
| 2017-12-31 | 26.86% | 2% | 2% | 3/158 | 9.68% | 誉衡药业 | 35.56% | 行业排名> |